|
Mean age at operation, y
|
54.6±16.1 (range -)
|
56.7±16.1 (range 14-79)
|
0.712
|
|
Sex, M:F (%)
|
17 (68):8 (32)
|
30 (57):23 (43)
|
0.458
|
|
Pancreatic duct diameter (mm)
| | | |
|
Before operation
| | |
0.153
|
|
Mean ± SD
|
3.5 ± 2.4
|
3.0 ± 1.9
| |
|
Median [range]
|
2.5 [1.0-10.0]
|
2.8 [1.0-9.0]
| |
|
After operation
| | |
0.000
|
|
Mean ± SD
|
5.7 ± 2.6
|
1.8 ± 0.6
| |
|
Median [range]
|
[3.3-13.0]
|
[1.0-3.0]
| |
|
Pancreatic parenchymal thickness (mm)
| | | |
|
Before operation
| | |
0.870
|
|
Mean ± SD
|
14.0 ± 4.9
|
14.3 ± 5.7
| |
|
Median [range]
|
18 [10.7-25.0]
|
17.4 [4.5-30.0]
| |
|
After operation
| | | |
|
Mean ± SD
|
9.5 ± 4.1
|
14.1 ± 4.9
|
0.000
|
|
Median [range]
|
11 [2.5-16.7]
|
14.7 [3.0-28.3]
| |
|
Type of operation, n (%)
| | |
1.000
|
|
Pancreaticoduodenectomy
|
24
|
49
| |
|
Segment resection of pancreas*
|
1
|
4
| |
|
Pancreatic duct stent retained > 2 years, n (%)
|
1 (4)
|
9 (17)
|
0.155
|
|
Adjuvant therapy, n (%)
|
9 (36)
|
11 (21)
|
0.397
|
|
I125 radioactive seeds implantation, n (%)
|
2 (8)
|
1 (2)
|
0.245
|
|
Pancreatic fistula, n (%)
|
3 (12)
|
14 (26)
|
0.240
|
|
Malignant tumor, n (%)
|
13 (52)
|
30 (57)
|
0.809
|
|
Follow-up period (mo)
| | |
0.551
|
|
Mean ± SD
|
39.8 ± 20.4
|
37.1 ± 22.0
| |
